Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses

Author： Papakostas G.I.   Ongur D.   Iosifescu D.V.   Mischoulon D.   Fava M.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.14, Iss.2, 2004-03, pp. : 135-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Deep Brain Stimulation: A New Treatment in Mood and Anxiety Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 6, 2014-08 ,pp. : 961-971

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: New Therapeutic Options for Anxiety and Mood Disorders)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 6, 2014-08 ,pp. : 927-929

Bentham Science Publishers

Access to resources Recommend Favorite

Riluzole in the Treatment of Mood and Anxiety Disorders

By Pittenger Christopher   Coric Vladimir   Banasr Mounira  

CNS Drugs, Vol. 22, Iss. 9, 2008-01 ,pp. : 761-786

Adis International

Access to resources Recommend Favorite

Anxiety and Mood Disorders and Cannabis Use

By Cheung Joyce T. W.   Mann Robert E.   Ialomiteanu Anca   Stoduto Gina   Chan Vincy   Ala-Leppilampi Kari   Rehm Jürgen  

The American Journal of Drug and Alcohol Abuse, Vol. 36, Iss. 2, 2010-03 ,pp. : 118-122

Informa Healthcare

Access to resources Recommend Favorite

Central functions of neuropeptide Y in mood and anxiety disorders

By Wu Gang   Feder Adriana   Wegener Gregers   Bailey Christopher   Saxena Shireen   Charney Dennis   Mathé Aleksander A  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 11, 2011-11 ,pp. : 1317-1331

Informa Healthcare

Access to resources Recommend Favorite